These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31251475)
1. Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines. Papavassiliou KA; Zoi I; Gargalionis AN; Koutsilieris M J Cell Mol Med; 2019 Sep; 23(9):6215-6227. PubMed ID: 31251475 [TBL] [Abstract][Full Text] [Related]
2. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer. Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959 [TBL] [Abstract][Full Text] [Related]
3. Divergent function of polycystin 1 and polycystin 2 in cell size regulation. Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373 [TBL] [Abstract][Full Text] [Related]
4. Polycystin-1 Enhances Stemmness Potential of Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Jung SH; You JE; Choi SW; Kang KS; Cho JY; Lyu J; Kim PH Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064452 [TBL] [Abstract][Full Text] [Related]
5. Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma. Gargalionis AN; Sarlani E; Stofas A; Malakou LS; Adamopoulos C; Bamias A; Boutati E; Constantinides CA; Stravodimos KG; Piperi C; Papavassiliou AG; Korkolopoulou P Cancer Lett; 2020 Oct; 489():135-143. PubMed ID: 32561414 [TBL] [Abstract][Full Text] [Related]
6. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. de Stephanis L; Bonon A; Varani K; Lanza G; GafĂ R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932 [TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis. Gargalionis AN; Malakou LS; Adamopoulos C; Piperi C; Theohari I; Nokhbehsaim M; Deschner J; Kokkalis G; Korkolopoulou P; Papadavid E; Papavassiliou AG; Basdra EK Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3468-3476. PubMed ID: 30077613 [TBL] [Abstract][Full Text] [Related]
8. Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1. Tang Y; Shi G; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z Biomed Res Int; 2019; 2019():5320747. PubMed ID: 31341901 [TBL] [Abstract][Full Text] [Related]
9. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56 Tang Y; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z Biomed Res Int; 2019; 2019():2582401. PubMed ID: 31641668 [TBL] [Abstract][Full Text] [Related]
10. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway. Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142 [TBL] [Abstract][Full Text] [Related]
11. A role for polycystin-1 and polycystin-2 in neural progenitor cell differentiation. Winokurow N; Schumacher S Cell Mol Life Sci; 2019 Jul; 76(14):2851-2869. PubMed ID: 30895336 [TBL] [Abstract][Full Text] [Related]
12. Polycystin-1: function as a mechanosensor. Dalagiorgou G; Basdra EK; Papavassiliou AG Int J Biochem Cell Biol; 2010 Oct; 42(10):1610-3. PubMed ID: 20601082 [TBL] [Abstract][Full Text] [Related]
13. Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. Li Y; Santoso NG; Yu S; Woodward OM; Qian F; Guggino WB J Biol Chem; 2009 Dec; 284(52):36431-36441. PubMed ID: 19854836 [TBL] [Abstract][Full Text] [Related]
14. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Shillingford JM; Murcia NS; Larson CH; Low SH; Hedgepeth R; Brown N; Flask CA; Novick AC; Goldfarb DA; Kramer-Zucker A; Walz G; Piontek KB; Germino GG; Weimbs T Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5466-71. PubMed ID: 16567633 [TBL] [Abstract][Full Text] [Related]
15. Polycystin and calcium signaling in cell death and survival. Lemos FO; Ehrlich BE Cell Calcium; 2018 Jan; 69():37-45. PubMed ID: 28601384 [TBL] [Abstract][Full Text] [Related]
17. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? Weimbs T Cell Cycle; 2006 Nov; 5(21):2425-9. PubMed ID: 17102641 [TBL] [Abstract][Full Text] [Related]
18. Altered trafficking and stability of polycystins underlie polycystic kidney disease. Cai Y; Fedeles SV; Dong K; Anyatonwu G; Onoe T; Mitobe M; Gao JD; Okuhara D; Tian X; Gallagher AR; Tang Z; Xie X; Lalioti MD; Lee AH; Ehrlich BE; Somlo S J Clin Invest; 2014 Dec; 124(12):5129-44. PubMed ID: 25365220 [TBL] [Abstract][Full Text] [Related]
19. Genetic Mechanisms of ADPKD. Kim DY; Park JH Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431 [TBL] [Abstract][Full Text] [Related]
20. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain. Kurbegovic A; Trudel M Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]